Impact of baseline characteristics and beta‐cell function on the efficacy and safety of subcutaneous once‐weekly semaglutide: A patient‐level, pooled analysis of the SUSTAIN 1‐5 trials

AIM: To evaluate the impact of relevant patient‐level characteristics on the efficacy and safety of subcutaneous, once‐weekly semaglutide in subjects with type 2 diabetes. MATERIALS AND METHODS: Exploratory post hoc analyses of pooled SUSTAIN 1‐5 (phase 3a) randomized, controlled trials examined the...

Descripción completa

Detalles Bibliográficos
Autores principales: Aroda, Vanita R., Capehorn, Matthew S., Chaykin, Louis, Frias, Juan P., Lausvig, Nanna L., Macura, Stanislava, Lüdemann, Jörg, Madsbad, Sten, Rosenstock, Julio, Tabak, Omur, Tadayon, Sayeh, Bain, Stephen C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065219/
https://www.ncbi.nlm.nih.gov/pubmed/31608552
http://dx.doi.org/10.1111/dom.13896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065219/
https://www.ncbi.nlm.nih.gov/pubmed/31608552
http://dx.doi.org/10.1111/dom.13896

Ejemplares similares